Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles.

Parimon T, Yao C, Habiel DM, Ge L, Bora SA, Brauer R, Evans CM, Xie T, Alonso-Valenteen F, Medina-Kauwe LK, Jiang D, Noble PW, Hogaboam CM, Deng N, Burgy O, Antes TJ, Konigshoff M, Stripp BR, Gharib SA, Chen P.

JCI Insight. 2019 Aug 8;5. pii: 129359. doi: 10.1172/jci.insight.129359.

2.

Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis.

Moodley YP, Corte TJ, Oliver BG, Glaspole IN, Livk A, Ito J, Peters K, Lipscombe R, Casey T, Tan DBA.

Respirology. 2019 Aug 8. doi: 10.1111/resp.13668. [Epub ahead of print]

PMID:
31393655
3.

Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis: A pilot study.

Majewski S, Tworek D, Szewczyk K, Kurmanowska Z, Antczak A, Górski P, Piotrowski WJ.

Clin Respir J. 2019 Aug 8. doi: 10.1111/crj.13075. [Epub ahead of print]

PMID:
31392802
4.

Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.

Zhang C, Cai R, Lazerson A, Delcroix G, Wangpaichitr M, Mirsaeidi M, Griswold AJ, Schally AV, Jackson RM.

Lung. 2019 Aug 7. doi: 10.1007/s00408-019-00257-w. [Epub ahead of print]

PMID:
31392398
5.

Crystal structure of pirfenidone (5-methyl-1-phenyl-1H-pyridin-2-one): an active pharmaceutical ingredient (API).

Barbero M, Mossotti M, Sironi A, Giovenzana GB, Colombo V.

Acta Crystallogr E Crystallogr Commun. 2019 Jun 11;75(Pt 7):984-986. doi: 10.1107/S2056989019006418. eCollection 2019 Jul 1.

6.

Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases.

Furukawa H, Oka S, Shimada K, Hashimoto A, Komiya A, Matsui T, Tohma S.

Clin Med Insights Circ Respir Pulm Med. 2019 Jul 30;13:1179548419866443. doi: 10.1177/1179548419866443. eCollection 2019.

7.

Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis.

Hill C, Li J, Liu D, Conforti F, Brereton CJ, Yao L, Zhou Y, Alzetani A, Chee SJ, Marshall BG, Fletcher SV, Hancock D, Ottensmeier CH, Steele AJ, Downward J, Richeldi L, Lu X, Davies DE, Jones MG, Wang Y.

Cell Death Dis. 2019 Aug 7;10(8):591. doi: 10.1038/s41419-019-1820-x.

8.

Choice of Methodology Impacts Outcome in Indirect Comparisons of Drugs for Idiopathic Pulmonary Fibrosis.

Scott DA, Loveman E, Colquitt JL, O'Reilly K.

Medicina (Kaunas). 2019 Aug 6;55(8). pii: E443. doi: 10.3390/medicina55080443.

9.

Seeing Deeply into the Lung in Interstitial Lung Disease.

Kaner RJ.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):857-858. doi: 10.1164/rccm.201709-1798ED. No abstract available.

PMID:
28957640

Supplemental Content

Loading ...
Support Center